Precision Biosciences (DTIL) Short-term Investments (2024 - 2026)

Precision Biosciences (DTIL) has 3 years of Short-term Investments data on file, last reported at $1.8 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (changed N/A YoY) and the FY2025 annual result came in at $4.8 million, up 1053.03% from the prior year.
• Short-term Investments fell to $1.8 million in Q1 2026 per DTIL's latest filing, from $4.8 million in the prior quarter.
• Across five years, Short-term Investments topped out at $4.8 million in Q4 2025 and bottomed at $413000.0 in Q4 2024.
• The 3-year median for Short-term Investments is $2.1 million (2024), against an average of $2.4 million.
• Peak annual rise in Short-term Investments reached 1053.03% in 2025, while the deepest fall reached 1053.03% in 2025.
• Tracing DTIL's Short-term Investments over 3 years: stood at $413000.0 in 2024, then jumped by 1053.03% to $4.8 million in 2025, then plunged by 61.91% to $1.8 million in 2026.
• Per Business Quant, the three latest DTIL Short-term Investments figures stand at $1.8 million (Q1 2026), $4.8 million (Q4 2025), and $413000.0 (Q4 2024).

Peer Comparison